These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6304480

  • 1. Active immunization with feline leukemia virus envelope glycoprotein suppresses growth of virus-induced feline sarcoma.
    Hunsmann G, Pedersen NC, Theilen GH, Bayer H.
    Med Microbiol Immunol; 1983; 171(4):233-41. PubMed ID: 6304480
    [Abstract] [Full Text] [Related]

  • 2. Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective.
    Pedersen NC, Johnson L, Birch D, Theilen GH.
    Vet Immunol Immunopathol; 1986 Feb; 11(2):123-48. PubMed ID: 3008409
    [Abstract] [Full Text] [Related]

  • 3. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK, de Noronha F, Tusch C, Michalek MT, McLane MF.
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [Abstract] [Full Text] [Related]

  • 4. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.
    Vedbrat SS, Rasheed S, Lutz H, Gonda MA, Ruscetti S, Gardner MB, Prensky W.
    Virology; 1983 Jan 30; 124(2):445-61. PubMed ID: 6186079
    [Abstract] [Full Text] [Related]

  • 5. Feline cytotoxic immune mechanisms against virus-associated leukemia and fibrosarcoma.
    McCarty JM, Grant CK.
    Cell Immunol; 1983 Oct 01; 81(1):157-68. PubMed ID: 6311439
    [Abstract] [Full Text] [Related]

  • 6. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
    Lehmann R, Franchini M, Aubert A, Wolfensberger C, Cronier J, Lutz H.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1446-52. PubMed ID: 1666101
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K, Pfauth A, van Herwijnen R, Jarrett O, Meloen RH, Tomee C, Osterhaus AD.
    Vaccine; 1993 Nov 15; 11(9):946-56. PubMed ID: 7692683
    [Abstract] [Full Text] [Related]

  • 13. Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein.
    Stephenson JR, Essex M, Hino S, Hardy WD, Aaronson SA.
    Proc Natl Acad Sci U S A; 1977 Mar 15; 74(3):1219-23. PubMed ID: 191832
    [Abstract] [Full Text] [Related]

  • 14. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
    Lutz H, Pedersen NC, Theilen GH.
    Am J Vet Res; 1983 Nov 15; 44(11):2054-9. PubMed ID: 6316819
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor alpha levels in cats experimentally infected with feline immunodeficiency virus: effects of immunization and feline leukemia virus infection.
    Lehmann R, Joller H, Haagmans BL, Lutz H.
    Vet Immunol Immunopathol; 1992 Dec 15; 35(1-2):61-9. PubMed ID: 1337403
    [Abstract] [Full Text] [Related]

  • 16. Infection with feline leukemia virus associated with induction of humoral response to a normal cell protein.
    Chen AP, Essex ME.
    Cancer Invest; 1984 Dec 15; 2(2):81-90. PubMed ID: 6329486
    [Abstract] [Full Text] [Related]

  • 17. Feline leukemia virus envelope glycoprotein vaccine: preparation and evaluation of immunizing potency in guinea pig and cat.
    Salerno RA, Lehman ED, Larson VM, Hilleman MR.
    J Natl Cancer Inst; 1978 Dec 15; 61(6):1487-93. PubMed ID: 214605
    [No Abstract] [Full Text] [Related]

  • 18. Feline leukemia vaccine: efficacy, contents and probable mechanism.
    Mastro JM, Lewis MG, Mathes LE, Sharpee R, Tarr MJ, Olsen RG.
    Vet Immunol Immunopathol; 1986 Mar 15; 11(3):205-13. PubMed ID: 3008410
    [Abstract] [Full Text] [Related]

  • 19. Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E.
    Langhammer S, Hübner J, Kurth R, Denner J.
    Immunology; 2006 Feb 15; 117(2):229-37. PubMed ID: 16423059
    [Abstract] [Full Text] [Related]

  • 20. Development and testing of an inactivated feline leukemia virus vaccine.
    Hoover EA, Mullins JI, Chu HJ, Wasmoen TL.
    Semin Vet Med Surg Small Anim; 1995 Nov 15; 10(4):238-43. PubMed ID: 8820598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.